CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Myocardial Infarction in Young Women Natural History of Spontaneous Coronary Artery Dissection With Spontaneous Angiographic Healing Healed Culprit Plaques in Patients With Acute Coronary Syndromes Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy Switching P2Y12-receptor inhibitors in patients with coronary artery disease Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When? An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Cardiac Shock Care Centers: JACC Review Topic of the Week Canadian SCAD Cohort Study: Shedding Light on SCAD From a United Front

Perspective2011 Oct 11;124(15):1636-44.

JOURNAL:Circulation Article Link

Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction

Miedema MD, Newell MC, Duval S et al. Keywords: ST-segment-elevation myocardial infarction; cause of delay

ABSTRACT


BACKGROUND - Regional ST-segment-elevation myocardial infarction systems are being developed to improve timely access to primary percutaneous coronary intervention (PCI). System delays may diminish the mortality benefit achieved with primary PCI in ST-segment-elevation myocardial infarction patients, but the specific reasons for and clinical impact of delays in patients transferred for PCI are unknown.


METHODS AND RESULTS - This was a prospective, observational study of 2034 patients transferred for primary PCI at a single center as part of a regional ST-segment-elevation myocardial infarction system from March 2003 to December 2009. Despite long-distance transfers, 30.4% of patients (n=613) were treated in ≤ 90 minutes and 65.7% (n=1324) were treated in ≤ 120 minutes. Delays occurred most frequently at the referral hospital (64.0%, n=1298), followed by the PCI center (15.7%, n=317) and transport (12.6%, n=255). For the referral hospital, the most common reasons for delay were awaiting transport (26.4%, n=535) and emergency department delays (14.3%, n=289). Diagnostic dilemmas (median, 95.5 minutes; 25th and 75th percentiles, 72-127 minutes) and nondiagnostic initial ECGs (81 minutes; 64-110.5 minutes) led to delays of the greatest magnitude. Delays caused by cardiac arrest and/or cardiogenic shock had the highest in-hospital mortality (30.6%), in contrast with nondiagnostic initial ECGs, which, despite long treatment delays, did not affect mortality (0%). Significant variation in both the magnitude and clinical impact of delays also occurred during the transport and PCI center segments.


CONCLUSIONS - Treatment delays occur even in efficient systems for ST-segment-elevation myocardial infarction care. The clinical impact of specific delays in interhospital transfer for PCI varies according to the cause of the delay.